Inside a MedTech Incubator’s Decision Process | Stan Rowe - CEO

In this MedTech Snapshot, Stan Rowe, CEO of Nidus Biomedical, walks through how a true medical device incubator evaluates opportunities before committing resources. From early concepts coming out of universities and physician ideas to strategic partnerships with established companies, Stan explains why “interesting” is never enough.

Not every problem in healthcare needs a device. And not every idea deserves the time, capital, and risk it takes to bring one to market.

For Nidus, everything starts with need. Does the idea create real value for patients? Will physicians care? Will payers pay? And will regulators ultimately approve it? Just as important, does it work well enough to actually change clinical practice, not just technically function.

Stan also addresses a hard truth in early-stage development. Some problems feel real but are not big enough to justify the cost, risk, and effort required to solve them, especially when Class III devices and nine-figure investments are involved.

Rather than acting as a contract engineering shop, Nidus focuses on moving upstream. Competitive analysis. Conversations with key opinion leaders. Pressure-testing existing products. The goal is to define what a product needs to be before a single major investment is made.

This first conversation sets the foundation for the rest of the series. It’s about discipline, judgment, and knowing when to say no so the yes decisions actually matter.

---

Looking for more support?
If you have questions about this topic or want to explore how our team can help with your MedTech project, contact us here.
Want to see what we do?
Visit our Services page or contact us directly to talk through your project and see if we’re the right fit.